- Global Pharma News & Resources

Hemodialys and Peritoneal Dialysis Market demand to be worth US$ 148.1 Billion by 2032 | Future Market Insights

The hemodialys and peritoneal dialysis market demand is supposed to develop at a CAGR of 6.1%, from USD 81.8 billion out of 2022 to USD 148.1 billion by 2032.

The rising number of ESRD patients, the rising commonness of diabetes and hypertension, the shortage of organ benefactors and the dangers related with transfers, mechanical headways, and drives by hemodialys and peritoneal dialysis market pioneers to present high level items and administrations are driving development in this hemodialys and peritoneal dialysis market.

Be that as it may, the risks and troubles associated with dialysis, as well as item reviews, are expected to restrict the hemodialys and peritoneal dialysis market’s improvement somewhat. The Covid pandemic is presently representing various issues to clinical medical care professionals and patients around the world.

Download Sample Copy@


  • In the type sector, Hemodialys from the Hemodialys and peritoneal dialysis market are anticipated to flourish at the quickest CAGR of 5.5% through 2032.
  • With a CAGR of 5.7% through 2032, Hospital Dialysis are predicted to grow significantly in the application sector of the Hemodialys and peritoneal dialysis market.
  • The market size for Hemodialys and peritoneal dialysis market in the United States is expected to reach US$ 49.4 Billion by 2032, growing at a CAGR of 6% during the research period.
  • China is anticipated to reach a market size of US$ 10.2 billion in Hemodialys and peritoneal dialysis by 2032, with a CAGR of 5.5% during the forecast period.
  • By 2032, South Korea is expected to reach a market size of US$ 5.3 Billion in Hemodialys and peritoneal dialysis, with a CAGR of 49% during the forecast period.

The expansion in the quantity of COVID cases, as well as the seriousness rate, is supposed to bring about an expansion in the frequency of renal injury. The worldwide requirement for renal substitution liquids has expanded decisively because of the pestilence. When contrasted with past US populaces, the requirement for RRT among COVID-19 patients has become fivefold.

Request for Customization@

The dynamic change toward home hemodialys treatment preceding the pandemic, as well as stresses over the spread of COVID-19 disease, has fundamentally expanded patient interest in HD treatment. During the pandemic, this element is supposed to build the utilization of home hemodialys supplies.

Arising economies including China, India, Brazil, and Mexico are probably going to give significant development possibilities to hemodialys and peritoneal dialysis suppliers. As per the US Renal Data System, Taiwan and Malaysia have the most elevated rate of treated ESRD in the 45-65 and 75 years age bunch.

To capitalise on the considerable growth prospects in emerging regions, firms are increasingly focused on strategic development agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions.

Furthermore, government support for ESRD therapy, the development of home/nocturnal dialysis, and the expanding number of dialysis clinics are fueling the expansion of the hemodialys and peritoneal dialysis market in developing nations.

The leading causes of death among dialysis patients are heart illnesses (arrhythmic mechanisms or sudden cardiac arrest) and vascular access-related issues such as bleeding and infection, low blood pressure, nausea, hernia, hepatitis (B & C), and anaemia.

Peritonitis is a frequent peritoneal dialysis complication caused by contamination of peritoneal dialysate or tubing with pathogenic skin germs or by catheter-related illnesses. Peritonitis kills 16% of Parkinson’s disease patients in North America each year. This restricts the use of dialysis techniques.

The hemodialys and peritoneal dialysis markets are dominated by North America. European is gaining momentum among the region’s enormous dialysis patient group. Factors such as a stronger reimbursement system in comparison to Europe and the Asia Pacific, the availability of professionals (nephrologists), and the presence of well-equipped dialysis clinics for patient treatment are pushing the hemodialys and peritoneal dialysis market.

Factors such as the growing preference for peritoneal dialysis and the rising use of home hemodialys (HHD) are driving the expansion of the hemodialys and peritoneal dialysis market.

Contact our Market Research Specialist@


The major players in the global hemodialys and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaver (US).


  • Mar Cor (Cantel Medical Corporation) announced the release of their unique EON Portable Hemodialys Water System in 2021.
  • Fresenius Medical Care AG & Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.
  • Baxter International Inc. gained FDA clearance for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialys (HDx) treatment in 2020.


By Type:

  • Hemodialys
  • Peritoneal dialysis

By End Use:

  • Hospital Based

By Product:

  • Device
  • Consumables
  • Services

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Top Related Reports Healthcare Market Insights–636e385b43b3d3e7dadb1bd2

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 14-Nov-2022